181 related articles for article (PubMed ID: 35062321)
1. Early T-cell reconstitution predicts risk of EBV reactivation after allogeneic hematopoietic stem cell transplantation.
Huang J; Pan Z; Wang L; Zhang Z; Huang J; Jiang C; Cai G; Yin T
Clin Exp Med; 2024 Jan; 24(1):22. PubMed ID: 38280072
[TBL] [Abstract][Full Text] [Related]
2. Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.
de Witte MA; Sarhan D; Davis Z; Felices M; Vallera DA; Hinderlie P; Curtsinger J; Cooley S; Wagner J; Kuball J; Miller JS
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1152-1162. PubMed ID: 29505821
[TBL] [Abstract][Full Text] [Related]
3. γδ T cells in oral diseases.
Wei XY; Tan YQ; Zhou G
Inflamm Res; 2024 May; 73(5):867-876. PubMed ID: 38563967
[TBL] [Abstract][Full Text] [Related]
4. Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications.
Wu HL; Weber WC; Shriver-Munsch C; Swanson T; Northrup M; Price H; Armantrout K; Robertson-LeVay M; Reed JS; Bateman KB; Mahyari E; Thomas A; Junell SL; Hobbs TR; Martin LD; MacAllister R; Bimber BN; Slifka MK; Legasse AW; Moats C; Axthelm MK; Smedley J; Lewis AD; Colgin L; Meyers G; Maziarz RT; Burwitz BJ; Stanton JJ; Sacha JB
Xenotransplantation; 2020 Jul; 27(4):e12578. PubMed ID: 31930750
[TBL] [Abstract][Full Text] [Related]
5. Dimorphism in the TCRγ-chain repertoire defines 2 types of human immunity to Epstein-Barr virus.
Djaoud Z; Parham P
Blood Adv; 2020 Apr; 4(7):1198-1205. PubMed ID: 32211881
[TBL] [Abstract][Full Text] [Related]
6. Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation.
Alexandersson A; Venäläinen MS; Heikkilä N; Huang X; Taskinen M; Huttunen P; Elo LL; Koskenvuo M; Kekäläinen E
Immunol Cell Biol; 2024 May; ():. PubMed ID: 38726587
[TBL] [Abstract][Full Text] [Related]
7. Spotlight on the impact of viral infections on Hematopoietic Stem Cells (HSCs) with a focus on COVID-19 effects.
Nasiri K; Mohammadzadehsaliani S; Kheradjoo H; Shabestari AM; Eshaghizadeh P; Pakmehr A; Alsaffar MF; Al-Naqeeb BZT; Yasamineh S; Gholizadeh O
Cell Commun Signal; 2023 May; 21(1):103. PubMed ID: 37158893
[TBL] [Abstract][Full Text] [Related]
8. Unlocking γδ T cell power: pathways that boost cancer defense.
Yao Y; Zong Z; Zhang L
Mol Biomed; 2024 Feb; 5(1):5. PubMed ID: 38311633
[No Abstract] [Full Text] [Related]
9. An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation.
Andrlová H; van den Brink MRM; Markey KA
Front Oncol; 2020; 10():608923. PubMed ID: 33680931
[TBL] [Abstract][Full Text] [Related]
10. Validation of analytical methods for the production of expanded γδ T lymphocytes useful for therapeutic purposes.
Morandi F; Della Lastra M; Zara F; Airoldi I
Curr Res Transl Med; 2024 Mar; 72(4):103445. PubMed ID: 38493557
[TBL] [Abstract][Full Text] [Related]
11. Variability of viral reactivations during recurrence of DRESS.
Rousset L; Caux F; Matcasu I; Khalifa B; Brechignac S; Assier H; Gaudin O; Musette P
Australas J Dermatol; 2024 Feb; 65(1):88-90. PubMed ID: 38108563
[No Abstract] [Full Text] [Related]
12. Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond.
Papadopoulou A; Alvanou M; Karavalakis G; Tzannou I; Yannaki E
Hemasphere; 2023 Jan; 7(1):e809. PubMed ID: 36698615
[TBL] [Abstract][Full Text] [Related]
13. AIM™ platform: A new immunotherapy approach for viral diseases.
Langan D; Wang R; Tidwell K; Mitiku S; Farrell A; Johnson C; Parks A; Suarez L; Jain S; Kim S; Jones K; Oelke M; Zeldis J
Front Med (Lausanne); 2022; 9():1070529. PubMed ID: 36619639
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Seasonal Fluctuation of γδ T Cells and Its Potential Relation with Vitamin D
Bernicke B; Engelbogen N; Klein K; Franzenburg J; Borzikowsky C; Peters C; Janssen O; Junker R; Serrano R; Kabelitz D
Cells; 2022 Apr; 11(9):. PubMed ID: 35563767
[TBL] [Abstract][Full Text] [Related]
15. Special Issue "Gamma Delta T Cells in Immune Response against Viruses".
Champagne E
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458466
[TBL] [Abstract][Full Text] [Related]
16. The Role of γδ T Cells as a Line of Defense in Viral Infections after Allogeneic Stem Cell Transplantation: Opportunities and Challenges.
Janssen A; van Diest E; Vyborova A; Schrier L; Bruns A; Sebestyen Z; Straetemans T; de Witte M; Kuball J
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062321
[TBL] [Abstract][Full Text] [Related]
17. A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications.
Hu Y; Cui Q; Luo C; Luo Y; Shi J; Huang H
Blood Rev; 2016 May; 30(3):179-88. PubMed ID: 26654098
[TBL] [Abstract][Full Text] [Related]
18. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
Düver F; Weißbrich B; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
PLoS One; 2020; 15(2):e0228451. PubMed ID: 32017805
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
